Unicycive Therapeutics, Inc. (UNCY)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-08-02 and 2026-10-31, public records show 1 signal for Unicycive Therapeutics, Inc.. Most notable: 2026-09-29: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-10-31 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-08-25Aggarwal GauravdirectorC652,900——
2025-08-25Aggarwal GauravdirectorC652,900——
2025-02-18Aggarwal GauravdirectorC1,400,000——
2025-02-18Aggarwal GauravdirectorC1,400,000——
2024-10-09Aggarwal GauravdirectorC5,500,000——
2024-10-09Aggarwal GauravdirectorC5,500,000——
2023-07-11Aggarwal GauravdirectorC3,470,152——
2023-07-11Jermasek DouglasofficerM104,612——
2023-07-11Gupta PramodofficerM41,845——
2023-07-11Gupta Shalabh K.directorM104,612——
2022-07-15Schiller BrigittedirectorM26,7380$0
2022-05-16Schiller BrigittedirectorP15,0000.83$12,375

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings